David Ginsburg
Non-Executive Director
Science & Technology Committee
shire Pharmaceuticals
United States of America
Biography
David brings to the Board his clinical medical experience in internal medicine, hematology-oncology and medical genetics, as well as his extensive basic biomedical laboratory research expertise. David will retire from the Board with effect from the conclusion of the 2018 Annual General Meeting. David obtained his BA at Yale University, MD at Duke University and completed his medical and research training at Harvard Medical School.
Research Interest
Biochemistry, Genetics& Molecular Biology
